Traditional Call Planning

White Paper

Has Traditional Call Planning Passed Its Prime?

This paper explores simple and more complex additions and solutions to a myriad of issues facing future changes to call planning. A central theme in all the proposed solutions is t ...

Future of Pharma - Evolving Commercial Models

Report

Future Of Pharma: Evolving Commercial Models – Part 1

The pharmaceutical industry is in a state of flux with the increasing influence of payers, pressure from the government with restricted healthcare budgets, and the rise of multi-ch ...

PBMs Pharma Benefit Manager

White Paper

Proposed Rule To End Rebates To PBMs For Medicare And Medicaid Programs

This white paper looks at how rebates to PBMs relate to drug prices from two perspectives: how they are supposed to work versus what actually happens. ...

Growing Attention Being Paid To Pharma Company Rebates And Discounts

White Paper

Growing Attention Being Paid To Pharma Company Rebates And Discounts

Pharma companies need to better understand how to manage rebates and discounts, while also developing a broader view of the effect on patients and the healthcare system. ...

Challenges And Opportunities To Commercialize Orphan Drugs For Rare Diseases In The US

White Paper

Challenges And Opportunities To Commercialize Orphan Drugs For Rare Diseases In The US

This white paper explores the unique challenges of ODs for RDs and the different approaches needed to address specific questions for their successful commercialization that vary fr ...

Perspectives On Pharma Company Use Of Open Payments Data

White Paper

Perspectives On Pharma Company Use Of Open Payments Data

This paper provides a detailed analysis on the role and effects of “Sunshine Laws” and payments made to providers as seen from published empirical evidence, intricacies and cha ...

How Regulatory Changes Are Driving The Future Of The Medical Device Industry

Report

How Regulatory Changes Are Driving The Future Of The Medical Device Industry

With new entrants from emerging countries giving the established brands a run for their money, the medical device market has become more competitive. ...

How Will The 2018 Midterm Congressional Election Results Affect The US Pharma Industry?

White Paper

How Will The 2018 Midterm Congressional Election Results Affect The US Pharma Industry?

The 2018 Congressional midterm elections are over after a bitter political fight. The voters have spoken. We are back to divided government, with Democrats controlling the House, a ...

Is The CVS-Aetna Merger A Pharma Industry Transformative Event?

White Paper

Is The CVS-Aetna Merger A Pharma Industry Transformative Event?

US antitrust officials recently approved the proposed $69 billion CVS-Aetna merger. This merger follows a similar action taken by the Justice Department to approve the Cigna-Expres ...

Deploying Successful Global Incentive Compensation Capabilities

White Paper

Deploying Successful Global Incentive Compensation Capabilities

There exists no single formula to solve the incentive compensation management puzzle, especially at a global scale across multiple geographies. The answer lies in a global IC plan ...

The Causes and Solutions of Chronic Drug Shortages in the United States

White Paper

The Causes and Solutions of Chronic Drug Shortages in the United States

While recent empirical research has exposed an array of causes for drug shortages, the application of better analytics has now also been cited as needed to account for these effect ...

Aligning Sales to the Field Force with Accurate IC Sales Crediting

White Paper

Aligning Sales to the Field Force – Increasing Complexities with Change in the Pharma Landscape

With this Whitepaper, unravel means of actual and correct sales crediting and therefore reduce pitfalls in incentive payouts through assigning correct addresses, managing shared ta ...

Machine Learning and Data Mining in Pharmaceutical Commercial Analytics

White Paper

The Value of Machine Learning and Data Mining in Pharmaceutical Commercial Analytics

Increasing complexities of the pharma environment also mean that machine learning can provide earlier anticipation of and faster responses to new threats and opportunities. ...

State Of Commercial Excellence 2017 - Part 1

Industry Survey

State Of Commercial Excellence 2017 – Part 1

Axtria recently launched a Commercial Excellence Survey to better understand the readiness of commercial organizations when facing these changing market realities. The survey inclu ...

Pharma Sales And Marketing Restrictions – Has the Pendulum Swung Too Far?

White Paper

Pharma Sales And Marketing Restrictions – Has the Pendulum Swung Too Far?

The question this commentary asks is simply this – has the pendulum swung too far in the direction of excessive restrictions on sales and marketing practices of biopharmaceut ...

Patient Claims Versus EHR Data – How To Choose Between The Two?

White Paper

Patient Claims Versus EHR Data – How To Choose Between The Two?

The topics this white paper will review are which dataset is more appropriate for answering certain types of business questions, look at some cases from the academic literature tha ...

White Paper

Better Reporting With The IPad

Good reporting is an essential tool for managing your business. This reporting needs to be focused and actionable – focused in that it addresses the key business questions you fa ...

White Paper

Payer Influence On Product Performance In Pharmaceutical Industry

Payers vary in their ability to assert formulary compliance. We will explore how tools and analytics can enable a pharmaceutical manufacturer to assess factors impacting formulary ...

White Paper

Account Based Models In An Institutional Setting

The stakeholders and factors that drive the ultimate prescribing of a medication have shifted considerably since the turn of the century. ...

Traditional Call Planning

White Paper

Has Traditional Call Planning Passed Its Prime?

This paper explores simple and more complex additions and solutions to a myriad of issues facing future changes to call planning. A central theme in all the proposed solutions is t ...

How Regulatory Changes Are Driving The Future Of The Medical Device Industry

Report

How Regulatory Changes Are Driving The Future Of The Medical Device Industry

With new entrants from emerging countries giving the established brands a run for their money, the medical device market has become more competitive. ...

Deploying Successful Global Incentive Compensation Capabilities

White Paper

Deploying Successful Global Incentive Compensation Capabilities

There exists no single formula to solve the incentive compensation management puzzle, especially at a global scale across multiple geographies. The answer lies in a global IC plan ...

Aligning Sales to the Field Force with Accurate IC Sales Crediting

White Paper

Aligning Sales to the Field Force – Increasing Complexities with Change in the Pharma Landscape

With this Whitepaper, unravel means of actual and correct sales crediting and therefore reduce pitfalls in incentive payouts through assigning correct addresses, managing shared ta ...

Evolution of Pharmaceutical Call Planning

White Paper

Evolution of Pharmaceutical Call Planning

This white paper will explore the factors used to develop account based call plans and how pharmaceutical companies’ must adapt to ensure their representatives are prepared and q ...

Achieving Sales Operations Excellence With Intelligent Roster Management

White Paper

Achieving Sales Operations Excellence With Intelligent Roster Management

Effective roster management has long been an overlooked topic in Pharma commercial operations. At any point in time, it is critical for the Sales Operations business processes to h ...

The Importance of Governance in Your Incentive Compensation Program

White Paper

The Importance of Governance in Your Incentive Compensation Program

In this white paper, we address the importance of IC Governance, its team make up, roles and responsibilities. We also go into the details of governing best practices towards plan ...

Designing Incentive Compensation Plans for Specialty Products

White Paper

Designing Incentive Compensation Plans for Specialty Products

The focus of this white paper is to highlight key challenges in designing IC plans for promoting specialty drugs by a pharmaceutical sales force and recommended best practices when ...

State Of Commercial Excellence 2017 - Part 1

Industry Survey

State Of Commercial Excellence 2017 – Part 1

Axtria recently launched a Commercial Excellence Survey to better understand the readiness of commercial organizations when facing these changing market realities. The survey inclu ...

Pharma Sales And Marketing Restrictions – Has the Pendulum Swung Too Far?

White Paper

Pharma Sales And Marketing Restrictions – Has the Pendulum Swung Too Far?

The question this commentary asks is simply this – has the pendulum swung too far in the direction of excessive restrictions on sales and marketing practices of biopharmaceut ...

Is Biopharmaceutical Industry Drug Demand Becoming More Recession Sensitive?

White Paper

Is Biopharmaceutical Industry Drug Demand Becoming More Recession Sensitive?

The Great Recession in the U.S. not only marked a period of the longest and by many measures the largest economic downturn since The Great Depression of the 1930’s, but also alte ...

Do You Know The Answers To Your Important Territory Alignment Questions

White Paper

Do You Know The Answers To Your Important Territory Alignment Questions

Do you know the answers to your important territory alignment questions? Or put another way, do you approach answering questions on your territory alignment issues like the blind s ...

Future of Pharma - Evolving Commercial Models

Report

Future Of Pharma: Evolving Commercial Models – Part 1

The pharmaceutical industry is in a state of flux with the increasing influence of payers, pressure from the government with restricted healthcare budgets, and the rise of multi-ch ...